Related Information
|
Covington Advises AstraZeneca on Agreement With Cubist Pharmaceuticals
7/11/2008
WASHINGTON, DC, July 11, 2008 — Cubist Pharmaceuticals, Inc. announced that it has signed an exclusive agreement with AstraZeneca to promote and provide support in the United States for MERREM® I.V. Covington & Burling LLP advised AstraZeneca on the deal.
AstraZeneca, a major international healthcare business, is engaged in the research, development, manufacturing and marketing of prescription medicines. Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
The Covington team included Washington-based partner John Hurvitz and San Francisco-based associate Amy Toro. The AstraZeneca legal team included Sara Ponessa and Richard Kenny.
|
|
|
|
|
|
|